”BCI collaborates with Redoxis for many years and we really appreciate study discussions, planning, flexibility and study reports.
Redoxis is a really competitive and expert CRO for in-vivo and in-vitro studies and with the sense of urgency.
I really recommend to use their platform and expertise.”
Dominique Surleraux, President and CEO
BCI Pharma